相关实验视频

Updated: Jul 14, 2026

An In Vitro Approach to Photodynamic Therapy

An In Vitro Approach to Photodynamic Therapy

Published on: August 17, 2018

卡尔西波特里作为日光光动力疗法增强剂:一个病例对照研究

Benedetta Sonego¹, Enrico Zelin², Serena Bonin³

¹Dermatology Clinic, Maggiore Hospital, University of Trieste. benedetta.sonego@gmail.com.

Dermatology reports

|March 18, 2025

概括

在白天光动力疗法 (DL-PDT) 之前先用皮醇 (CAL) 膏治疗动力性角质瘤 (AKs),显著改善了病变清除. 这种组合疗法提供了一种耐受良好的方法来管理AKs,可能防止状细胞癌的发展.

科学领域:

皮肤病学皮肤病学
在瘤学瘤学.
照相医疗 (photomedicine) 是一种医学.

背景情况:

行为性角质 (AKs) 是常见的,太阳引起的皮肤病变.
AKs是被认可的状细胞癌 (SCC) 的前体.
目前对AK的治疗方法具有不同的疗效和副作用.

研究的目的:

为了评估结合皮醇 (CAL) 膏预处理与白天光动力学疗法 (DL-PDT) 对AKs的疗效.
评估CAL预治疗对AK病变严重程度和清除的影响.
为了确定组合治疗方案的安全性和耐受性.

主要方法:

一项观察性病例控制研究,涉及20名患有I-II级AKs的男性患者.
患者被随机分配到一个病例组 (CAL膏+DL-PDT) 和一个控制组 (保湿剂+DL-PDT).
治疗涉及14天的CAL预治疗,然后是三个DL-PDT会议,评估使用Actinic Keratosis Area Severity Index (AKASI) 在基线,3个月和6个月.

主要成果:

与对照组相比,CAL治疗前组的AKASI分数在统计学上显著下降.
随着CAL + DL-PDT组合,观察到行动性角质的增强清除.
综合治疗被很好地容忍,报告的副作用很少.

结论:

卡尔西波特里膏的预处理可以提高白天光动力疗法对行为性角质的疗效.
这种综合方法为管理AKS提供了有效和安全的策略.
这些发现表明,有可能防止AK进展为状细胞癌.

更多相关视频

Daily Phototherapy with Red Light to Regulate Candida albicans Biofilm Growth

Daily Phototherapy with Red Light to Regulate Candida albicans Biofilm Growth

Published on: April 23, 2019

Rose Bengal-Mediated Photodynamic Therapy to Inhibit Candida albicans

Rose Bengal-Mediated Photodynamic Therapy to Inhibit Candida albicans

Published on: March 24, 2022

相关概念视频

Blinding

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.